2025-04-24 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**0) Summary Statistics:**

Colgate-Palmolive Co (CL) is a leading manufacturer and distributor of household and personal care products.  The company's cumulative return significantly lags the S&P 500 (VOO).  Recent price action shows a slight downward trend, and while some financial metrics are strong, others warrant further investigation.


**1) Performance Comparison:**

* **Company Overview:** Colgate-Palmolive Co is a multinational consumer goods company specializing in oral hygiene products, personal care items, and pet food.

* **Cumulative Return:**
    * CL: 39.56%
    * VOO (S&P 500): 78.93%
    * **Difference:** -39.37%  (CL underperformed VOO by 39.37% at the end of the period.)

* **Alpha and Beta Analysis:** The provided data shows inconsistent alpha and beta values across different periods. While some periods show positive alpha (outperformance relative to the market), others show negative alpha. Beta is relatively stable, indicating a moderate level of market sensitivity.  Further analysis is needed to interpret these fluctuations.  Note that the large MDD (Maximum Drawdown) values in the earlier periods indicate substantial potential risks.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 16.0% | 4.2% | -16.0% | 0.1 | 52.3 |
| 2016-2018  | -9.0% | 65.3% | -30.0% | 0.1 | 42.2 |
| 2017-2019  | 10.0% | 65.3% | -24.0% | -0.3 | 50.1 |
| 2018-2020  | 22.0% | 65.3% | -8.0% | 0.3 | 63.7 |
| 2019-2021  | 34.0% | 58.5% | -26.0% | 0.8 | 65.0 |
| 2020-2022  | 11.0% | 68.9% | 2.0% | 0.7 | 61.5 |
| 2021-2023  | 8.0% | 68.9% | -13.0% | 0.6 | 63.8 |
| 2022-2024  | 16.0% | 68.9% | -5.0% | 0.5 | 74.4 |
| 2023-2025  | 17.0% | 62.4% | 0.0% | 0.2 | 77.7 |


**2) Recent Price Action:**

* **Closing Price:** $93.89
* **Previous Close:** $95.81
* **Change:** -$2.00 (-2.09%)
* **5-day MA:** $94.57
* **20-day MA:** $92.75
* **60-day MA:** $90.40

The price is below its 5-day and 20-day moving averages, suggesting a short-term downtrend. However, it is above the 60-day MA, indicating some longer-term support.  The recent price drop of $2.00 reflects a notable decline.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4174 (Medium Risk)
* **RSI:** 51.79 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.2767 (Positive, suggesting bullish momentum but not excessively strong)
* **20-day Relative Divergence Change:** +0.1 (Slight positive divergence, suggesting potential upward momentum)
* **Expected Return:** -63.6%  This extremely negative expected return relative to the S&P 500 needs further explanation and context.  The timeframe (2+ years) should be clarified, as well as the methodology used for this projection.


**4) Recent Earnings Analysis:**

The recent earnings data shows relatively stable revenue but inconsistent EPS.  Further analysis is needed to determine the underlying drivers of these trends and their implications.


| Date       | EPS | Revenue      |
|------------|-----|--------------|
| 2024-10-25 | 0.9 | $5.03 B      |
| 2024-07-26 | 0.89 | $5.06 B      |
| 2024-04-26 | 0.83 | $5.07 B      |
| 2023-10-27 | 0.86 | $4.92 B      |
| 2024-10-25 | 0.86 | $4.92 B      |  *(Duplicate entry, likely a data error)*


**5) Financial Information:**

Revenue remains relatively stable, but the profit margin fluctuates slightly.  The equity and ROE figures show extreme volatility, raising concerns about the reliability or accuracy of the provided data.  Such high and erratic ROE values are unusual and warrant further investigation.  


**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30% |
| 2024-09-30 | $5.03B | 61.08% |
| 2024-06-30 | $5.06B | 60.62% |
| 2024-03-31 | $5.07B | 60.00% |
| 2023-12-31 | $4.95B | 59.60% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $0.21B | 348.58% |
| 2024-09-30 | $0.43B | 169.43% |
| 2024-06-30 | $0.12B | 594.31% |
| 2024-03-31 | $0.23B | 296.96% |
| 2023-12-31 | $0.61B | 117.90% |


**6) Overall Analysis:**

Colgate-Palmolive shows some positive aspects (stable revenue, generally healthy profit margins) but also significant concerns. The significant underperformance compared to the S&P 500 (-39.37%), the highly volatile ROE figures, and the extremely negative projected return require further scrutiny. The data provided contains inconsistencies (duplicate earnings data, erratic ROE) that must be resolved before a comprehensive investment decision can be made.  Independent verification of the data and a deeper dive into the company's fundamentals and industry trends are strongly recommended. The high maximum drawdown figures also highlight significant risk.  Caution is advised.
